Development decisions are increasingly made early, based on strategic hypotheses (positioning, differentiation, claims, access pathway), while the competitive landscape and payer/authority expectations keep evolving.
Teams must translate strategic documents (TPP, clinical strategy, launch plan) into concrete evidence needs, then verify whether existing evidence packs already cover those needs - or whether gaps could block future time-to-market.
Without a structured approach, evidence planning becomes reactive, fragmented, and difficult to prioritize.
3× faster gap mapping
Turn strategy, target claims, market expectations, and existing evidence packs into a structured claim-to-evidence matrix faster.
Late evidence gaps identified earlier
Surface missing, weak, or misaligned evidence earlier with a gap heatmap across claims, endpoints, populations, comparators, markets, and stakeholder expectations.
Evidence roadmap by market
Prioritize next evidence-generation actions by market — studies, RWE, SLRs, HEOR analyses, publications, or dossier updates — with source-linked rationale.
How it works
1
Ingest product strategy — import key documents (TPP, clinical strategy, access/HEOR strategy, claims, target markets) and structure objectives and hypotheses to be validated.
2
Cross with competitive intelligence — retrieve and summarize competitor signals (approvals, labels, HTA decisions, endpoints, comparators, RWE/HEOR patterns) to calibrate the expected level of evidence.
3
Compare against existing evidence packs — map each need (claim/endpoint/population/comparator/market) to evidence already available in your packs to identify gaps, redundancies, and risks.
4
Prioritize and plan future evidence — generate an evidence roadmap (studies, RWE, SLR, HEOR analyses, publications) with prioritization, justification, and traceability back to strategy and competition.
Claim-to-evidence matrix: map each strategic claim to available evidence, supporting sources, target markets, stakeholder expectations, and confidence level.
Gap heatmap + roadmap: translate weak or missing evidence into prioritized actions by market, indication, comparator, endpoint, and lifecycle objective.